Health & Medicine · Pharmacokinetics
Clearance Calculator (Pharmacology)
Calculates drug clearance from volume of distribution and elimination rate constant, or from dose and AUC, for pharmacokinetic analysis.
Calculator
Formula
CL is total drug clearance (L/h or mL/min); V_d is the volume of distribution (L); k_e is the first-order elimination rate constant (h⁻¹); F is bioavailability (fraction, 0–1); D is the administered dose (mg); AUC_{0→∞} is the area under the plasma concentration–time curve from zero to infinity (mg·h/L).
Source: Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. 4th ed. Lippincott Williams & Wilkins, 2010.
How it works
Drug clearance (CL) is a fundamental pharmacokinetic concept that quantifies the body's ability to eliminate a drug. It is defined as the volume of blood or plasma from which a drug is completely and irreversibly removed per unit time. Clearance is an additive property — total body clearance is the sum of renal clearance, hepatic clearance, and all other elimination pathways. Because clearance directly determines the steady-state plasma concentration achieved with a given dosing rate, it is critical for designing safe and effective drug dosing schedules.
Two equivalent methods exist to calculate clearance. In the Vd × ke method, clearance is the product of the volume of distribution (Vd, in litres) and the first-order elimination rate constant (ke, in h⁻¹): CL = Vd × ke. The volume of distribution represents the apparent volume into which a drug distributes relative to its plasma concentration, while ke reflects the fractional rate at which drug is removed. In the Dose/AUC method, CL = F × D / AUC₀₋∞, where F is bioavailability, D is the administered dose, and AUC is the area under the plasma concentration–time curve. Both formulations yield identical results for the same drug and patient when measured correctly. The half-life (t½ = 0.693 / ke = 0.693 × Vd / CL) is also derived from these parameters and represents the time for plasma concentration to fall by half.
Clearance values are used across a wide range of clinical and research applications: adjusting doses in patients with renal or hepatic impairment, predicting steady-state drug concentrations during continuous or repeated dosing, comparing bioequivalence between formulations, and scaling pharmacokinetic data from animals to humans. For renally eliminated drugs, creatinine clearance or GFR is often used as a surrogate to estimate drug clearance and guide dose modifications in patients with kidney disease.
Worked example
Method 1 — Vd × ke: A patient receives an antibiotic with a measured volume of distribution of Vd = 40 L and an elimination rate constant of ke = 0.12 h⁻¹.
CL = Vd × ke = 40 L × 0.12 h⁻¹ = 4.8 L/h = 80 mL/min.
The elimination half-life is t½ = 0.693 / 0.12 = 5.78 hours.
Method 2 — Dose/AUC: A patient receives an intravenous bolus dose of 500 mg (F = 1.0 for IV). The AUC from 0 to infinity is measured as 104.2 mg·h/L.
CL = (1.0 × 500 mg) / 104.2 mg·h/L = 4.80 L/h ≈ 80 mL/min — consistent with method 1.
Both methods confirm clearance of approximately 80 mL/min, which in this example approximates normal renal function, suggesting the drug is primarily renally eliminated.
Limitations & notes
Clearance calculated from Vd and ke assumes a one-compartment pharmacokinetic model with first-order elimination. Many drugs follow multi-compartment kinetics, in which case a single ke is an oversimplification and clearance should be derived from AUC. The AUC method is model-independent but requires accurate numerical integration over the full elimination profile, including extrapolation to infinity — errors in the terminal slope estimation will propagate into clearance. Bioavailability (F) is often assumed rather than measured, particularly for oral drugs; using an incorrect F will cause proportional error in CL. Clearance is not constant across all dose ranges for drugs exhibiting saturable (Michaelis-Menten) elimination kinetics, such as phenytoin. Clearance can change with age, body weight, organ function, drug interactions, and disease state, so values derived in one population may not apply universally. This calculator should be used as a clinical decision support tool and not as a substitute for individualized therapeutic drug monitoring or specialist pharmacokinetic consultation.
Frequently asked questions
What is drug clearance and why does it matter?
Drug clearance is the volume of plasma completely cleared of a drug per unit time (expressed in L/h or mL/min). It is the key parameter that determines steady-state plasma concentration during continuous or repeated dosing: Css = Dosing rate / CL. Understanding clearance allows clinicians to individualize doses and maintain therapeutic drug levels.
What is a normal range for drug clearance?
There is no single 'normal' range — clearance varies enormously between drugs based on their physicochemical properties and routes of elimination. For example, creatinine clearance (a proxy for renal drug clearance) is approximately 100–120 mL/min in healthy adults. For a specific drug, reference values are found in its pharmacokinetic literature or prescribing information.
How does renal impairment affect drug clearance?
For renally eliminated drugs, clearance decreases proportionally with declining glomerular filtration rate (GFR). This reduction leads to drug accumulation and toxicity if doses are not adjusted. Dose adjustments in renal impairment are typically guided by the fraction of drug eliminated renally (fe) and the patient's estimated creatinine clearance or eGFR.
What is the difference between clearance and volume of distribution?
Clearance (CL) governs the rate of drug elimination and determines steady-state concentrations. Volume of distribution (Vd) describes how extensively a drug distributes into body tissues relative to plasma. Together, they define the elimination half-life: t½ = 0.693 × Vd / CL. A high Vd with low CL results in a long half-life.
Can I use this calculator for oral drug dosing?
Yes — when using the Dose/AUC method for an orally administered drug, enter the bioavailability fraction (F, typically 0–1) as measured or reported in the drug's pharmacokinetic data. For intravenous administration, F = 1.0. The Vd × ke method is independent of the route of administration, as ke is derived from the plasma elimination phase after distribution is complete.
Last updated: 2025-01-15 · Formula verified against primary sources.